Brief: Novan Reports Safety Data From B-SIMPLE4 Pivotal Phase 3 Study Of SB206
Sept 23 (Reuters) - Novan Inc NOVN.O :
* NOVAN REPORTS SAFETY DATA FROM B-SIMPLE4 PIVOTAL PHASE 3
STUDY
OF SB206
* NOVAN INC - SB206 DEMONSTRATES CONTINUED FAVORABLE SAFETY
PROFILE CONSISTENT WITH PREVIOUS STUDIES AND MEETS COMPANY'S
EXPECTATIONS
* NOVAN INC - PRE-NDA MEETING WITH FDA, AS WELL AS CONDUCT
OF
CUSTOMARY STABILITY TESTING, TARGETED FOR 1H 2022
* NOVAN INC - POTENTIAL NDA SUBMISSION ON TRACK, TARGETING
Q3 2022
Source text for Eikon: ID:nGNX2z1cmk
Further company coverage: NOVN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NVN Liquidation
See all newsBrief: Nvn Liquidation Says On April 30, Debtors Filed Notice Of Effective Date With Bankruptcy Court
Brief: Novan Received Notice From Nasdaq Notifying Co's Securities Will Be Delisted From Nasdaq
Brief: Novan Received Notice Of Delisting Or Failure To Satisfy Continued Listing Rule From Nasdaq
U.S. STOCKS ON THE MOVE-Lands' End, Energy sector
U.S. STOCKS ON THE MOVE-Biogen, NetApp, LyondellBasell